Novocure Ltd (NVCR) financials
Novocure revenue and earnings by year
Novocure's revenue was $655 million in the fiscal year to December 31, 2025, up 8.3% from the year before. Net income was -$136 million, -20.8% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 25.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 655 | 605 | 509 | 538 | 535 | 494 | 351 | 248 | 177 | 83 |
| Revenue growth | 8.3% | 18.8% | -5.3% | 0.5% | 8.2% | 40.7% | 41.6% | 40.1% | 113.6% | — |
| Gross profit | 488 | 468 | 381 | 423 | 420 | 388 | 263 | 168 | 121 | 37 |
| Gross margin | 74.5% | 77.3% | 74.8% | 78.6% | 78.5% | 78.5% | 74.8% | 67.7% | 68.6% | 44.2% |
| Operating income | -154 | -170 | -233 | -90 | -44 | 30 | -1 | -34 | -39 | -115 |
| Operating margin | -23.5% | -28.2% | -45.7% | -16.6% | -8.3% | 6.1% | -0.3% | -13.6% | -22.2% | -139.1% |
| Net income | -136 | -169 | -207 | -93 | -58 | 20 | -7 | -64 | -62 | -132 |
| Net margin | -20.8% | -27.9% | -40.6% | -17.2% | -10.9% | 4.0% | -2.1% | -25.6% | -34.8% | -159.1% |
| Diluted EPS | -$1.22 | -$1.56 | -$1.95 | -$0.88 | -$0.56 | $0.19 | -$0.08 | -$0.70 | -$0.71 | -$1.54 |
| Free cash flow | -76 | -69 | -100 | 9 | 59 | 84 | 16 | -9 | -41 | -125 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open NVCR in Markets.
See also: NVCR returns
No forecast, no recommendation. This page describes Novocure Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.